SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 117.60 |
| Enterprise Value ($M) | 193.40 |
| Book Value ($M) | -84.83 |
| Book Value / Share | -2.69 |
| Price / Book | -1.39 |
| NCAV ($M) | -139.53 |
| NCAV / Share | -4.43 |
| Price / NCAV | -0.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.68 |
| Return on Assets (ROA) | 0.13 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.14 |
| Current Ratio | 1.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 68.68 |
| Assets | 123.38 |
| Liabilities | 208.21 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 197.19 |
| Operating Income | 31.61 |
| Net Income | 3.16 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 45.24 |
| Cash from Investing | -18.80 |
| Cash from Financing | -76.08 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Roystone Capital Management LP | 12.00 | 27.89 | |
| 13G/A | Bandera Partners LLC | 7.50 | 32.90 | |
| 13G | BlackRock, Inc. | 5.30 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 42,438 | 198,118 | 21.42 | |
| 34,187 | 137,415 | 24.88 | |
| 38,554 | 1,156,989 | 3.33 | |
| 23,074 | 190,869 | 12.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AXSM – Axsome Therapeutics, Inc. | BCAB – BioAtla, Inc. |
| BHST – BioHarvest Sciences Inc. | CADL – Candel Therapeutics, Inc. |
| CARM – Carisma Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io